
CivicaScript Launches Low-Cost Cancer Drug To Make Treatment More Affordable
Potential savings of $1,500/month compared with other generic versions CivicaScript, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, announced the availability